Friday, February 13, 2026
  • Login
Euro Times
No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
Euro Times
No Result
View All Result

Italy’s Cucinelli and EssilorLuxottica sign eyewear license accord By Reuters

by Reuters
November 21, 2022
in Stock Market
Reading Time: 1 min read
A A
0
Home Stock Market
Share on FacebookShare on Twitter


2/2
© Reuters. FILE PHOTO: Glasses manufactured by EssilorLuxottica, stand on display in their exhibition space at SILMO in Villepinte, near Paris, France September 24, 2022. REUTERS/Benoit Tessier

2/2

MILAN (Reuters) – Brunello Cucinelli signed an exclusive license deal with French-Italian glasses maker EssilorLuxottica for the design, manufacture and distribution of eyewear under the Italian luxury group’s brand, the two companies said in a statement on Monday.

The new ten-year agreement will be effective from next January, while the first collection of glasses will be launched in the first quarter of 2024.

The deal is an extension of the current collaboration between the two firms that began in 2021, including a capsule collection signed by Brunello Cucinelli and EssilorLuxottica’s exclusive brand Oliver Peoples, they added.



Source link

Tags: AccordCucinelliEssilorLuxotticaeyewearItalysLicenseReuterssign
Previous Post

Budget 2023: Infra sector seeks rationalisation of GST, easier bank credit

Next Post

Ep. 406: Revolutionary Real Estate Tech (with Neema Bardi)

Related Posts

Columbia Threadneedle Fixed Income Monitor: February 2026

Columbia Threadneedle Fixed Income Monitor: February 2026

by Columbia Threadneedle Investments
February 13, 2026
0

Columbia Threadneedle Investments is a number one world asset administration group that gives a broad vary of actively managed funding...

CareDx, Inc. (CDNA) Discusses AlloHeme Clinical Validation Data Review and Launch Timeline in AML and MDS Post-Cell Therapy Transcript

CareDx, Inc. (CDNA) Discusses AlloHeme Clinical Validation Data Review and Launch Timeline in AML and MDS Post-Cell Therapy Transcript

by SA Transcripts
February 12, 2026
0

Operator Hiya, and thanks for standing by. Presently, I want to welcome everybody to the CareDx Investor Webinar Name. I...

A New Generation Of Buyback Indices: Introducing The S&P 500 Buyback Aristocrats Index

A New Generation Of Buyback Indices: Introducing The S&P 500 Buyback Aristocrats Index

by Euro Times
February 12, 2026
0

At S&P Dow Jones Indices, our function will be described in a single phrase: important. We’re the biggest world useful...

Biotricity, Inc. (BTCY) Q3 2026 Earnings Call Transcript

Biotricity, Inc. (BTCY) Q3 2026 Earnings Call Transcript

by SA Transcripts
February 11, 2026
0

ObservePlay Earnings NamePlay Earnings Name Biotricity, Inc. (BTCY) Q3 2026 Earnings Name February 11, 2026 4:30 PM EST Firm Individuals...

Aging Trade-Ins Collide With Surging Global Demand for Pre-Owned Smartphones, According to New Data Released from Circana and B-Stock

Aging Trade-Ins Collide With Surging Global Demand for Pre-Owned Smartphones, According to New Data Released from Circana and B-Stock

by Editorial Team
February 11, 2026
0

San Mateo, CA and Chicago, IL, Feb. 11, 2026 (GLOBE NEWSWIRE) — New knowledge from each Circana and B-Inventory reveals...

Exelixis, Inc. 2025 Q4 – Results – Earnings Call Presentation (NASDAQ:EXEL) 2026-02-11

Exelixis, Inc. 2025 Q4 – Results – Earnings Call Presentation (NASDAQ:EXEL) 2026-02-11

by SA Transcripts
February 11, 2026
0

This autumn: 2026-02-10 Earnings AbstractEPS of $0.94 beats by $0.13  | Income of $598.66M (5.63% Y/Y) misses by $19.10KThis text was...

Next Post
Ep. 406: Revolutionary Real Estate Tech (with Neema Bardi)

Ep. 406: Revolutionary Real Estate Tech (with Neema Bardi)

Guidelines for receiving foreign hospitality revised

Guidelines for receiving foreign hospitality revised

Why were Pompeii residents wearing heavy wool during August eruption? Researchers reveal new evidence | World News

Why were Pompeii residents wearing heavy wool during August eruption? Researchers reveal new evidence | World News

February 13, 2026
IREN Stock: Execution De‑Risk And Secured Capacity Drives Growth (NASDAQ:IREN)

IREN Stock: Execution De‑Risk And Secured Capacity Drives Growth (NASDAQ:IREN)

February 13, 2026
Judge blocks Trump plan to cut health grants to Democratic-led states : NPR

Judge blocks Trump plan to cut health grants to Democratic-led states : NPR

February 13, 2026
Columbia Threadneedle Fixed Income Monitor: February 2026

Columbia Threadneedle Fixed Income Monitor: February 2026

February 13, 2026
Share Market Live February 13: Sensex, Nifty set for cautious start after global tech stocks slide

Share Market Live February 13: Sensex, Nifty set for cautious start after global tech stocks slide

February 13, 2026
Xiaomi’s electric SUV tops China sales in January, sells twice as many as Tesla’s Model Y

Xiaomi’s electric SUV tops China sales in January, sells twice as many as Tesla’s Model Y

February 13, 2026
Euro Times

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Finance
  • Health
  • Investing
  • Markets
  • Politics
  • Stock Market
  • Technology
  • Uncategorized
  • World

LATEST UPDATES

Why were Pompeii residents wearing heavy wool during August eruption? Researchers reveal new evidence | World News

IREN Stock: Execution De‑Risk And Secured Capacity Drives Growth (NASDAQ:IREN)

  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In